Investment - Mystic News

USFDA Approval: Alembic Pharma’s Proven $110M Otic Solution

JustinOctober 19, 2026

USFDA approval Alembic Pharma brings a new $110M otic suspension to market, ensuring safe treatment options.

Law

Patent Costs: Understanding the Investment in Innovation

Nancy BellFebruary 8, 2025

Innovation and creativity are the driving forces behind revolutionary products and ideas. However, securing those ideas through patents involves a…

Recent
Popular

pharma

Retail Prices of Drugs: Clear Insights on New Pricing Changes

JustinNovember 5, 2026

retail prices of drugs have been fixed by India’s NPPA for 34 new medications, marking a significant change in the pharmaceutical landscape. Overview of the New Drug Prices The National Pharmaceutical Pricing Authority (NPPA) of India has recently announced significant changes in the retail prices…

pharma

Drug price controls: The Worst Threat to Medical Innovation

JustinNovember 3, 2026

drug price controls are becoming a significant concern in Washington, threatening medical innovation. As lawmakers push for price regulations, the implications for future drug development could be dire. Understanding Drug Price Controls Drug price controls have emerged as a contentious issue in the ongoing debate…

pharma

USFDA Approval Venetoclax: Is It the Best Treatment Option?

JustinOctober 30, 2026

What is coveredWhat is Venetoclax?Impact of USFDA ApprovalBenefits of Venetoclax TabletsFuture of Alembic Pharmaceuticals USFDA approval Venetoclax tablets is a major achievement for Alembic Pharmaceuticals, enhancing treatment options for patients. This approval signifies a step forward in cancer therapy. What is Venetoclax? Venetoclax is an…

pharma

Cancer drug price cap: Is it the worst deal for patients?

JustinOctober 28, 2026

On this pageUnderstanding the Cancer Drug Price CapImpact on Patients and HealthcareComparison of Generic and Patented PricesGovernment Regulations on Drug PricingFuture of Cancer Treatment AffordabilityExpert Opinions on Pricing Strategies The cancer drug price cap has raised concerns among patients and healthcare providers. Despite steep cuts…

pharma

Tag: investment

USFDA Approval: Alembic Pharma’s Proven $110M Otic Solution

Patent Costs: Understanding the Investment in Innovation

Retail Prices of Drugs: Clear Insights on New Pricing Changes

Drug price controls: The Worst Threat to Medical Innovation

USFDA Approval Venetoclax: Is It the Best Treatment Option?

Cancer drug price cap: Is it the worst deal for patients?

Retail Prices of Drugs: Clear Insights on New Pricing Changes

Drug price controls: The Worst Threat to Medical Innovation

USFDA Approval Venetoclax: Is It the Best Treatment Option?

Cancer drug price cap: Is it the worst deal for patients?

Latst Post

Retail Prices of Drugs: Clear Insights on New Pricing Changes

Drug price controls: The Worst Threat to Medical Innovation

USFDA Approval Venetoclax: Is It the Best Treatment Option?

Cancer drug price cap: Is it the worst deal for patients?